Managing Liquidity
Liquidity is a persistent challenge for OTC derivative market participants. Effective risk management practices driven by in-depth data is paramount if businesses are to navigate the unpredictable waters ahead.
The global financial crisis forced OTC market players to think more seriously about the very real risk of institutional failure.
Regulators on both sides of the Atlantic stepped in with rules designed to improve transparency and reduce systemic risk. But while the Dodd-Frank Act in the United States and the European Market Infrastructure Regulation (EMIR) in Europe may have achieved these aims, largely by driving much of the trading activity on centralised clearing platforms, participants now must manage the unintended consequence of reduced liquidity.
As Dave Ramsden, Deputy Governor of Markets and Banking at the Bank of England, notes, while the ubiquitous use of collateral has financial stability benefits, including by facilitating hedging of firm-level interest rate risk and significant reduction in counterparty credit risk, “it has led both to an increase in system-wide liquidity needs and an increased importance for effective risk management of idiosyncratic liquidity risks at individual firms”.1
Add to this the shorter intraday settlement cycles against which financial institutions must monitor, manage and reserve in persistently volatile markets, funding and liquidity challenges are unlikely to abate anytime soon.
OTC derivatives players have no choice but to navigate illiquid markets, which means ensuring they have access to the right data, market analytics and risk management systems. Only those organisations that develop and implement robust liquidity risk management policies – encompassing liquidity stress testing, liquidity measurement and risk limits – have the best chance in surviving the most stressful conditions.
Hard-working data
OTC derivative market participants need full sight of the markets in which they operate. This means not only accessing real-time data but having an ability to analyse historical information.
Exploring past events that had an impact on liquidity within derivatives markets – such as the 2008 financial crisis, the 2020 COVID-19 pandemic or the 2022 gilt crisis – can help inform risk management processes today.
Parameta Solutions, the data and analytics division of TP ICAP Group which is the world’s largest inter-broker dealer, has unrivalled indicative and transactional data which comes with full history for all the markets we cover. Our depth of coverage supports clients with generating alpha, price discovery, risk management and valuation tasks so they can meet regulatory and compliance requirements.
Reliable stress-testing
Employing effective stress-testing techniques that evaluate the resilience of financial institutions and derivatives markets under adverse conditions focusing on liquidity scenarios are critical.
Exploring how different derivatives react to changes in market conditions, such as heightened volatility or shifts in interest rates or assessing the resilience of derivatives to liquidity shocks and their ability to maintain market functioning, make a genuine difference to how players understand the impact of market liquidity. Stress testing is essential to ensuring organisations have contingency plans in place and are well protected during difficult markets.
Our in-depth, consistent and robust market data informs reliable stress testing. We have more than 20 years of historical price data which can be incorporated into research processes helping to identify patterns, validate hypotheses and make more informed decisions.
Advanced technology
The role of leading technologies including artificial intelligence, machine learning and automation is already becoming clear in the OTC derivatives space. These advances make analysing data which identifies shifts in market structures and the necessary responses from OTC derivatives participants more reliable, faster and ultimately help to minimise disruption.
Technology is at the core of Parameta Solutions’ operation; we always have one eye on the future and constantly assess the key trends and shifting dynamics of an ever-changing marketplace. This agility helps us to deliver the best possible results for our clients and, in turn, ensures that they can future-proof their own businesses. Adapting to the ever-evolving landscape of liquidity risk in derivatives trading means robust risk management practices informed by consistent, reliable data. Parameta offers a range of innovative solutions to keep your business ahead of the curve.
Bibliography
© 2024 ICAP Information Services Limited (“IISL”). This communication is provided by ICAP Information Services Limited or a member of its group (“Parameta”) and all information contained in or attached hereto (the “Information”) is for information purposes only and is confidential. Access to the Information by anyone other than the intended recipient is unauthorised without Parameta’s prior written approval. The Information may not be not used or disclosed for any purpose without Parameta’s prior written approval, including without limitation, storing, copying, distributing, licensing, selling or displaying the Information, using the Information in an application or to create derived data of any kind, co-mingling the Information with any other data or using the data for any unlawful purpose of for any purpose that would cause it to become a benchmark under any law, regulation or guidance.
The Information is not, and should not be construed as, a live price, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy or constituting financial or investment advice or a financial promotion. The Information is not to be relied upon for any purpose whatsoever and is provided “as is” without warranty of any kind, either expressly or by implication, including without limitation as to completeness, timeliness, accuracy, continuity, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed, to the fullest extent possible under applicable law. In no circumstances will Parameta be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of, any inability to use, or any inaccuracy in the Information. Parameta may suspend, withdraw or modify or change the terms of the provision of the Information at any time in its sole discretion, without notice.
All rights, including without limitation intellectual property rights, in and to the Information are, and shall remain, the property of IISL or its licensors. Use of, access to or delivery of Parameta’s products and/or services requires a prior written licence from Parameta or its relevant affiliates. The terms of this disclaimer are governed by the laws of England and Wales.
